(BLCM) |
| 0 (0%) 01-13 20:27 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 0.11 |
| Resistance 1: | 0.09 |
| Pivot price: | 0.08 |
| Support 1: | 0.06 |
| Support 2: | 0.05 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -0.670 |
| Book Value | -2.780 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | -77.40 |
| Return on Assets (ttm) | -78.1 |
| Return on Equity (ttm) | -148.5 |
Company news
Fri, 05 Dec 2025
Engineered nanofibrous membrane as an in-vitro corneal model for drug permeation studies - ScienceDirect.com
Sat, 24 Feb 2024
Bellicum Pharmaceuticals Appoints New CEO During Dissolution - TipRanks
Fri, 06 Oct 2023
Has Persecution Intensified in Bangladesh? - International Christian Concern
Fri, 08 Jul 2022
Jonathan Garsson (Forest Sciences) | UBC Forestry & Environmental Stewardship - The University of British Columbia
Mon, 08 Feb 2021
Ponce Therapeutics Inc. Commences First R & D Program in Anti-Aging Products for Skin - PR Newswire
Tue, 08 Dec 2020
Bellicum hit by FDA hold after trial death 'unrelated' to CAR-T therapy - The Pharma Letter
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
